This brand name is authorized in Austria, Canada, Estonia, Spain, Finland, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania, United Kingdom, United States
The drug PROCYSBI contains one active pharmaceutical ingredient (API):
|
1
Mercaptamine
UNII QO84GZ3TST - CYSTEAMINE BITARTRATE
|
|
Mercaptamine reduces corneal cystine crystal accumulation acting as a cystine-depleting agent by converting cystine to cysteine and cysteine-cysteamine mixed disulfides. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| PROCYSBI Capsule / Granules | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| A16AA04 | Mercaptamine | A Alimentary tract and metabolism → A16 Other alimentary tract and metabolism products → A16A Other alimentary tract and metabolism products → A16AA Amino acids and derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: CA | Health Products and Food Branch | Identifier(s): 02464705, 02464713 |
| Country: EE | Ravimiamet | Identifier(s): 1624845, 1624856 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 113861001, 113861002 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 436647, 494885 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 65249056, 69022853 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 307180, 307186 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 88990, 88991 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 043041019, 043041021, 043041033, 043041045 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1071193, 1071194 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100313291, 100313300 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W66425001, W66426001 |
| Country: US | FDA, National Drug Code | Identifier(s): 75987-100, 75987-101, 75987-140, 75987-145 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
